Effect of Hippotherapy and Schroth Exercise on Pulmonary Function and Aerobic Capacity in Idiopathic Scoliosis

Overview

BACKGROUND: Idiopathic scoliosis has been identified as a common spinal malalignment that negatively impacts the respiratory system and physical conditioning in adolescents. Hippotherapy is an equestrian intervention that optimizes physical performance and mobility in a bunch of contexts; however, its influence on pulmonary function remains unclear. AIM: This research aimed to analyze the impact of ten weeks of hippotherapy combined with Schroth exercises on ventilatory function and aerobic capacity in AIS. DESIGN: Randomized Controlled Trial SETTING: Outpatients attend a single center that includes a rehabilitation room and recreational riding center. POPULATION: Forty-five patients were arbitrarily recruited to the experimental (N= 22) and control group (N=23). METHODS: Patients in the experimental group received 30 minutes of walking and sitting trot training, 15 sessions split into 2 phases over ten weeks. The two groups attended a 60-minute session of Schroth's intervention, 3 times/ week for 10 weeks. Two-way ANOVA for between-group comparisons and independent t-test for within-group comparisons were used in the statistical analysis.

Full Title of Study: “Efficacy of Hippotherapy Combined With Schroth Exercises on Pulmonary Function and Aerobic Capacity in Adolescents With Idiopathic Scoliosis: A Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 18, 2020

Detailed Description

A total of 45 patients (13 males and 32 females) participated in the current study. The participants were assigned to one of two groups in a random manner: an experimental group who received hippotherapy combined with Schroth Exercise and the control group who received only schorth exercise. (FVC, FEV1, FEV1/FVC, MVV, and 6MWT) were measured before and after 10 weeks intervention

Interventions

  • Other: hippotherapy and schroth exercise
    • pulmonary function and aerobic capacity were measured in patients with mild idiopathic scoliosis before and after 10-week hippotherapy intervention combined with Schroth exercise
  • Other: schroth exercise
    • pulmonary function and aerobic capacity were measured in patients with mild idiopathic scoliosis before and after 10-week of Schroth exercise

Arms, Groups and Cohorts

  • Experimental: hippotherapy combined with Schroth Exercise
    • received hippotherapy combined with Schroth Exercise hippotherapy session for 30 minutes of walking and sitting trot training, 15 sessions split into 2 phases over ten weeks in addition to 60-minute session Schroth’s intervention, 3 times/ week for 10 weeks
  • Active Comparator: Schroth Exercise
    • received Schroth’s intervention for a 60-minute session, 3 times/ week for 10 weeks

Clinical Trial Outcome Measures

Primary Measures

  • FVC in liters
    • Time Frame: ten weeks
    • change in FVC measured Using Spiromaster PC-10 Spirometer
  • FEV1 in liters
    • Time Frame: ten weeks
    • change in FEV1 measured Using Spiromaster PC-10 Spirometer
  • MVV in liters/min
    • Time Frame: ten weeks
    • change in MVV measured Using Spiromaster PC-10 Spirometer
  • FEV1/FVC in percentage
    • Time Frame: ten weeks
    • change in FEV1/FVC measured Using Spiromaster PC-10 Spirometer
  • aerobic capacity
    • Time Frame: ten weeks
    • 6MWT

Participating in This Clinical Trial

Inclusion Criteria

  • all types of curves, – curves between 10 and 20 degrees (29), – Risser grade 0 to 5 – the availability to be engaged in once a week visit Exclusion Criteria:

Adolescents with:

  • obstructive pulmonary diseases – associated neuromuscular diseases – recent infectious episodes in the previous two months – history of cardiovascular or psychological disorders – any significant history of riding horses

Gender Eligibility: All

Minimum Age: 12 Years

Maximum Age: 18 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Batterjee Medical College
  • Collaborator
    • Taif University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Mohamed A. Abdel Ghafar, associate Professor – Batterjee Medical College
  • Overall Official(s)
    • Mohamed M. Abdel Ghafar, Ph.D, Principal Investigator, Batterjee Medical College

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.